Tech Company Financing Transactions

ProteoGenix Funding Round

On 3/9/2007, ProteoGenix raised $20 million in Series B financing from Burrill & Company, New Leaf Venture Partners and TPG Capital.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

3545 Howard Way
Costa Mesa, CA 92626
USA

Phone

(714) 445-0100

Website

www.proteogenix.com

Email Address

[email protected]

Overview

ProteoGenix has utilized high-throughput protein analysis techniques to identify protein biomarkers for pregnancy-related complications.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Don Mooney

        

Chief Medical Officer

Durlin Hickok

        

Co-Founder

Michael Gravett

        

Vice President

Mike Allen

        

Vice President

Thomas Grove

        

VP - Regulatory Affairs

Robert Di Tullio

        

Browse more venture capital transactions:

Prev: 3/9/2007: Ahura Scientific venture capital transaction
Next: 3/9/2007: Tapatap venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary